J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 78 (1997), 1913-1918
© 1997 Society for General Microbiology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Baalen, C. A.
Right arrow Articles by Osterhaus, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Baalen, C. A.
Right arrow Articles by Osterhaus, A. D.
Agricola
Right arrow Articles by van Baalen, C. A.
Right arrow Articles by Osterhaus, A. D.

Journal of General Virology, Vol 78, 1913-1918, Copyright © 1997 by Society for General Microbiology

ARTICLES

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS

CA van Baalen, O Pontesilli, RC Huisman, AM Geretti, MR Klein, F de Wolf, F Miedema, RA Gruters and AD Osterhaus
Institute of Virology, Erasmus University Rotterdam, The Netherlands.

Immunological correlates of AIDS-free survival after human immunodeficiency virus type 1 (HIV-1) infection are largely unknown. Cytotoxic T lymphocyte (CTL) responses are generally believed to be a major component of protective immunity against viral infections. However, the relationship between HIV-1-specific CTL responses and disease progression rate is presently unclear. Here we show in twelve HIV-1-infected individuals that detection of Rev-specific CTL precursors (CTLp) early in the asymptomatic stage, as well as detection of Rev- and Tat-specific CTLp later during follow-up, inversely correlate with rapid disease progression. No such correlation was found for detection of CTLp against Gag, RT or Nef. Further studies are required to determine whether a protective mechanism is indeed the basis of the observed correlation. The data presented are in agreement with the hypothesis that CTL against proteins that are important for early viral transcription and translation are of particular importance in protection from rapid disease progression.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Schildknecht, S. Welti, M. B. Geuking, L. Hangartner, and M. van den Broek
Absence of CTL Responses to Early Viral Antigens Facilitates Viral Persistence
J. Immunol., March 1, 2008; 180(5): 3113 - 3121.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. Demberg, R. H. Florese, M. J. Heath, K. Larsen, I. Kalisz, V. S. Kalyanaraman, E. M. Lee, R. Pal, D. Venzon, R. Grant, et al.
A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques
J. Virol., April 1, 2007; 81(7): 3414 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. H. Mealey, J.-H. Lee, S. R. Leib, M. H. Littke, and T. C. McGuire
A Single Amino Acid Difference within the {alpha}-2 Domain of Two Naturally Occurring Equine MHC Class I Molecules Alters the Recognition of Gag and Rev Epitopes by Equine Infectious Anemia Virus-Specific CTL
J. Immunol., November 15, 2006; 177(10): 7377 - 7390.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Z. Wang, B. Metcalf, R. M. Ribeiro, H. McClure, and A. Kaur
Th-1-Type Cytotoxic CD8+ T-Lymphocyte Responses to Simian Immunodeficiency Virus (SIV) Are a Consistent Feature of Natural SIV Infection in Sooty Mangabeys
J. Virol., March 15, 2006; 80(6): 2771 - 2783.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Kittiworakarn, A. Lecoq, G. Moine, R. Thai, E. Lajeunesse, P. Drevet, C. Vidaud, A. Menez, and M. Leonetti
HIV-1 Tat Raises an Adjuvant-free Humoral Immune Response Controlled by Its Core Region and Its Ability to Form Cysteine-mediated Oligomers
J. Biol. Chem., February 10, 2006; 281(6): 3105 - 3115.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Hel, W.-P. Tsai, E. Tryniszewska, J. Nacsa, P. D. Markham, M. G. Lewis, G. N. Pavlakis, B. K. Felber, J. Tartaglia, and G. Franchini
Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes
J. Immunol., January 1, 2006; 176(1): 85 - 96.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. E. Tebo, M. J. Fuller, D. E. Gaddis, K. Kojima, K. Rehani, and A. J. Zajac
Rapid Recruitment of Virus-Specific CD8 T Cells Restructures Immunodominance during Protective Secondary Responses
J. Virol., October 15, 2005; 79(20): 12703 - 12713.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X. Liang, D. R. Casimiro, W. A. Schleif, F. Wang, M.-E. Davies, Z.-Q. Zhang, T.-M. Fu, A. C. Finnefrock, L. Handt, M. P. Citron, et al.
Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys
J. Virol., October 1, 2005; 79(19): 12321 - 12331.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Mascarell, C. Fayolle, C. Bauche, D. Ladant, and C. Leclerc
Induction of Neutralizing Antibodies and Th1-Polarized and CD4-Independent CD8+ T-Cell Responses following Delivery of Human Immunodeficiency Virus Type 1 Tat Protein by Recombinant Adenylate Cyclase of Bordetella pertussis
J. Virol., August 1, 2005; 79(15): 9872 - 9884.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Ramakrishna, K. K. Anand, K. M. Mohankumar, and U. Ranga
Codon Optimization of the Tat Antigen of Human Immunodeficiency Virus Type 1 Generates Strong Immune Responses in Mice following Genetic Immunization
J. Virol., September 1, 2004; 78(17): 9174 - 9189.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
B. Makitalo, P. Lundholm, J. Hinkula, C. Nilsson, K. Karlen, A. Morner, G. Sutter, V. Erfle, J. L. Heeney, B. Wahren, et al.
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen
J. Gen. Virol., August 1, 2004; 85(8): 2407 - 2419.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. Frahm, B. T. Korber, C. M. Adams, J. J. Szinger, R. Draenert, M. M. Addo, M. E. Feeney, K. Yusim, K. Sango, N. V. Brown, et al.
Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities
J. Virol., March 1, 2004; 78(5): 2187 - 2200.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Draenert, C. L. Verrill, Y. Tang, T. M. Allen, A. G. Wurcel, M. Boczanowski, A. Lechner, A. Y. Kim, T. Suscovich, N. V. Brown, et al.
Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection
J. Virol., January 15, 2004; 78(2): 630 - 641.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. C. Probst, K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek
Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression
J. Immunol., November 15, 2003; 171(10): 5415 - 5422.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Cao, J. McNevin, U. Malhotra, and M. J. McElrath
Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection
J. Immunol., October 1, 2003; 171(7): 3837 - 3846.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
I. Tikhonov, T. J. Ruckwardt, G. S. Hatfield, and C. D. Pauza
Tat-Neutralizing Antibodies in Vaccinated Macaques
J. Virol., March 1, 2003; 77(5): 3157 - 3166.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. M. Addo, X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al.
Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load
J. Virol., February 1, 2003; 77(3): 2081 - 2092.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Voss, K. Manson, D. Montefiori, D. I. Watkins, J. Heeney, M. Wyand, J. Cohen, and C. Bruck
Prevention of Disease Induced by a Partially Heterologous AIDS Virus in Rhesus Monkeys by Using an Adjuvanted Multicomponent Protein Vaccine
J. Virol., December 20, 2002; 77(2): 1049 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X. Jin, X. Gao, M. Ramanathan Jr., G. R. Deschenes, G. W. Nelson, S. J. O'Brien, J. J. Goedert, D. D. Ho, T. R. O'Brien, and M. Carrington
Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+-T-Cell Responses for Groups of HIV-1-Infected Individuals with Different HLA-B*35 Genotypes
J. Virol., November 13, 2002; 76(24): 12603 - 12610.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. M. Allen, L. Mortara, B. R. Mothe, M. Liebl, P. Jing, B. Calore, M. Piekarczyk, R. Ruddersdorf, D. H. O'Connor, X. Wang, et al.
Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication
J. Virol., March 19, 2002; 76(8): 4108 - 4112.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Fanales-Belasio, S. Moretti, F. Nappi, G. Barillari, F. Micheletti, A. Cafaro, and B. Ensoli
Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses
J. Immunol., January 1, 2002; 168(1): 197 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. R. Betts, D. R. Ambrozak, D. C. Douek, S. Bonhoeffer, J. M. Brenchley, J. P. Casazza, R. A. Koup, and L. J. Picker
Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection
J. Virol., December 15, 2001; 75(24): 11983 - 11991.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
B. Korber, B. Gaschen, K. Yusim, R. Thakallapally, C. Kesmir, and V. Detours
Evolutionary and immunological implications of contemporary HIV-1 variation
Br. Med. Bull., September 1, 2001; 58(1): 19 - 42.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Guan, J. B. Whitney, M. Detorio, and M. A. Wainberg
Construction and In Vitro Properties of a Series of Attenuated Simian Immunodeficiency Viruses with All Accessory Genes Deleted
J. Virol., May 1, 2001; 75(9): 4056 - 4067.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
M. Schutten, C. A. van Baalen, C. Guillon, R. C. Huisman, P. H. M. Boers, K. Sintnicolaas, R. A. Gruters, and A. D. M. E. Osterhaus
Macrophage Tropism of Human Immunodeficiency Virus Type 1 Facilitates In Vivo Escape from Cytotoxic T-Lymphocyte Pressure
J. Virol., March 15, 2001; 75(6): 2706 - 2709.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
Y. Guan, J. B. Whitney, C. Liang, and M. A. Wainberg
Novel, Live Attenuated Simian Immunodeficiency Virus Constructs Containing Major Deletions in Leader RNA Sequences
J. Virol., March 15, 2001; 75(6): 2776 - 2785.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. M. Addo, M. Altfeld, E. S. Rosenberg, R. L. Eldridge, M. N. Philips, K. Habeeb, A. Khatri, C. Brander, G. K. Robbins, G. P. Mazzara, et al.
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
PNAS, February 13, 2001; 98(4): 1781 - 1786.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. G. Murphy, W. T. Lucas, R. E. Means, S. Czajak, C. L. Hale, J. D. Lifson, A. Kaur, R. P. Johnson, D. M. Knipe, and R. C. Desrosiers
Vaccine Protection against Simian Immunodeficiency Virus by Recombinant Strains of Herpes Simplex Virus
J. Virol., September 1, 2000; 74(17): 7745 - 7754.
[Abstract] [Full Text]

Home page
 J. Gen. Virol.Home page
M. E. van der Ende, C. Guillon, P. H. M. Boers, R. A. Gruters, P. Racz, K. Tenner-Racz, A. D. M. E. Osterhaus, and M. Schutten
Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model
J. Gen. Virol., February 1, 2000; 81(2): 507 - 513.
[Abstract] [Full Text]

Home page
 J. Gen. Virol.Home page
S. A. Ansari, M. Safak, G. L. Gallia, B. E. Sawaya, S. Amini, and K. Khalili
Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity
J. Gen. Virol., October 1, 1999; 80(10): 2629 - 2638.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
S. A. Calarota, A.-C. Leandersson, G. Bratt, J. Hinkula, D. M. Klinman, K. J. Weinhold, E. Sandstrom, and B. Wahren
Immune Responses in Asymptomatic HIV-1-Infected Patients After HIV-DNA Immunization Followed by Highly Active Antiretroviral Treatment
J. Immunol., August 15, 1999; 163(4): 2330 - 2338.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Caselli, M. Betti, M. P. Grossi, P. G. Balboni, C. Rossi, C. Boarini, A. Cafaro, G. Barbanti-Brodano, B. Ensoli, and A. Caputo
DNA Immunization with HIV-1 tat Mutated in the trans Activation Domain Induces Humoral and Cellular Immune Responses Against Wild-Type Tat
J. Immunol., May 1, 1999; 162(9): 5631 - 5638.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
J. Karlas, K. Siebelink, M. Peer, W Huisman, A. Cuisinier, G. Rimmelzwaan, and A. Osterhaus
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection
J. Gen. Virol., March 1, 1999; 80(3): 761 - 765.
[Abstract]

Home page
 J. Virol.Home page
C. A. Van Baalen, M. Schutten, R. C. Huisman, P. H. M. Boers, R. A. Gruters, and A. D. M. E. Osterhaus
Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro
J. Virol., August 1, 1998; 72(8): 6851 - 6857.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. A. Migueles, M. S. Sabbaghian, W. L. Shupert, M. P. Bettinotti, F. M. Marincola, L. Martino, C. W. Hallahan, S. M. Selig, D. Schwartz, J. Sullivan, et al.
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
PNAS, March 14, 2000; 97(6): 2709 - 2714.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. D. Pauza, P. Trivedi, M. Wallace, T. J. Ruckwardt, H. Le Buanec, W. Lu, B. Bizzini, A. Burny, D. Zagury, and R. C. Gallo
Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques
PNAS, March 28, 2000; 97(7): 3515 - 3519.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.